Mehmet Karabey

Dr. Mehmet Karabey


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
NKNuran Karabulut
Nuran Karabulut
SASema Alacam
Sema Alacam
EŞEsranur Şen
Esranur Şen
MKMehmet Karabey
Mehmet Karabey
NYNurhayat Yakut
Nurhayat Yakut
Respiratory tract infections (RTIs) can lead to both recurrent seasonal epidemic outbreaks and devastating pandemics. The aim of this study was to evaluate the epidemiologic characteristics and pathogen spectrum of RTIs using a multiplex RT-PCR panel. A total of 9354 cases with suspected RTIs between February 2021 and July 2023 were included in this study. A total of 11,048 nasopharyngeal and oropharyngeal samples from these patients were analyzed for 23 respiratory tract pathogens using multiplex RT-PCR. H. influenzae and S. pneumoniae were considered as colonizing bacteria. At least one pathogen was detected in 70.66% of the samples; viral pathogens were detected in 48.41% of the samples, bacterial pathogens were detected in 16.06% of the samples, and viral + bacterial pathogens were detected in 35.53% of the samples. The most frequently detected viral pathogen was rhinovirus/enterovirus (RV/EV) (19.99%). Interestingly, in 2021, respiratory syncytial virus A/B showed atypical activity and replaced RV/EV as the most prevalent pathogen. Human bocavirus, H. influenzae, and S. pneumoniae were detected at higher rates in males (p: 0.038, p: 0.042, and p: 0.035, respectively), while SARS-CoV-2 and B. pertussis were detected at higher rates in females (p < 0.001 and p: 0.033). RTIs were found at higher rates in children (p < 0.001). SARS-CoV-2 and human coronaviruses 229E were detected at higher rates in adults (p < 0.001 and p: 0.001). This comprehensive study with a large sample size investigating RTI pathogens was the first in Türkiye. Understanding the current viral circulation using multiplex RT-PCR panels enables clinicians to predict the most likely pathogens affecting patients and contributes to patient management, in addition to anticipating potential threats.

1 November 2024 in Annals of Saudi Medicine
Verified
Journal Article
Open access
MKMehmet Karabey
Mehmet Karabey
SASema Alacam
Sema Alacam
NKNuran Karabulut
Nuran Karabulut
HUHayriye Uysal
Hayriye Uysal
AGAlper Gunduz
Alper Gunduz
OAOzlem Altuntas Aydina
Ozlem Altuntas Aydina
BACKGROUND: Hepatitis A infections continue to be a major global public health problem. The epidemiology and seroprevalence of hepatitis A virus (HAV) have important public health implications. This study aimed to retrospectively examine the hepatitis A cases and hepatitis A seroprevalence in our region in our hospital with the highest number of inpatient and outpatient cases in Istanbul. OBJECTIVE: Determination of hepatitis A cases and seroprevalence. DESIGN: Cross-sectional. SETTING: Tertiary care. PATIENTS AND METHODS: A total of 39 385 individuals who were tested for Anti-HAV IgM and Anti-HAV Total (IgM+IgG) antibodies between May 2020 and September 2023 and were included in this study. Hepatitis A specific IgM and Total (IgM+IgG) antibodies were determined using the enzyme-linked immunosorbent assay method. MAIN OUTCOME MEASURE: Hepatitis A seroprevalence. SAMPLE SIZE: 46 721 RESULTS: The study included a total of 46 721 samples from 39 385 individuals who were tested for hepatitis A serology. The median age of the 39385 individuals included in the study was 28 (interquartile range [IQR]; 22–46), with 58.74% being female and 4.07% (n=1163) being foreign nationals. Reactivity was detected in 91 of the 25 442 patients tested for HAV-IgM. Among these patients, 33 (0.13%) had acute hepatitis A infection, while 58 (0.23%) were considered false positives. Of the acute hepatitis A patients, 13 (0.09%) were women, and 22 (0.80%) were children. Acute hepatitis A was most commonly observed in the 6–9 and 15–18 age groups, with 7 cases each. The seroprevalence rate of hepatitis A was 67.23% among 33 683 individuals. Of those tested for HAV-Total, 13 132 (64.92%) were women, and 2533 (64.88%) were children. The lowest seroprevalence rate among age groups (35.91%) was in the 15–18 age year range, while the highest seroprevalence (98.34%) was detected in individuals aged 60 years and above. CONCLUSION: With a seroprevalence rate of 67.23%, our region is still considered a medium-endemic area for hepatitis A, and it is crucial to continue administering the HAV vaccine as currently included in the childhood vaccination schedule in our country. Additionally, the significantly low hepatitis A seropositivity, particularly in the 15–18 and 19–24 age groups, indicates the need to promote catch-up vaccination for young adults. Since our study covers a large population, it can serve as a guide regarding the serological status of hepatitis A in Istanbul. LIMITATIONS: Since vaccination information for the study population was not available, it was not possible to distinguish between seropositivity due to vaccination or natural immunity. Despite being conducted in Istanbul, a cosmopolitan city, and in the largest city hospital, the results may not be representative of the entire country.

3 June 2025 in Mediterranean Journal of Infection Microbes and Antimicrobials
Verified
Journal Article
Open access
PDF file
MKMehmet Karabey
Mehmet Karabey
NKNuran Karabulut
Nuran Karabulut
SASema Alacam
Sema Alacam
Current Status on the Epidemiology of Hepatitis B Virus Infection in İstanbul - Mediterranean Journal of Infection Microbes and Antimicrobials

21 September 2025 in Paediatrics & Child Health
Verified
Journal Article
Closed access
MKMehmet Karabey
Mehmet Karabey
HKHatice Selda Kaya
Hatice Selda Kaya
Objectives: Acute respiratory infections(ARIs) represent a major global public health concern and affect all age groups. Children are infected approximately two to three times more frequently than adults. This study aimed to evaluate the prevalence and seasonality of viral pathogens associated with respiratory tract infections in children in our region. Materials and Methods: Between January 2019 and December 2024, respiratory viral pathogens were analyzed using the Rotor-GeneQ MDxdevice (Qiagen, Germany) with the FastTrack Diagnostics "FTD Respiratory Pathogens 21 Assay" multiplex real-time PCR kit. Results: The most frequently detected viral pathogen was RSV A/B (25.18%), while the least detected was PIV1 (0.54%). The most common pathogens were RSV A/B in 2019 and 2023, RSV A/B in 2020, PIV3 in 2021, RSVA/B in 2022, and Rhinovirus in 2024. RSV A/B was the most frequently detected virus in both girls and boys. HMPV A/B was significantly more common in males (p<0.05). Viral pathogens were detected in 73.60% of individuals aged ≤1 year, with RSV A/B being the most frequently identified. ARIs peaked during the winter months and were lowest in the summer. ARIs reached their highest level in December and dropped significantly in August. RSV A/B predominated in December, January, February, and March; Rhinovirus in April, May, and June; Adenovirus in July, August, September, and October; and Bocavirus in November. Conclusion: Monitoring the annual and seasonal distribution of respiratory viruses is critical for predicting and identifying epidemics and pandemics. This approach can help ensure accurate pathogen identification and prevent inappropriate antimicrobial treatments.

31 December 2024 in Archives of Rheumatology
Verified
Journal Article
Open access
PDF file
MKMehmet Karabey
Mehmet Karabey
HKHAVVA KAYA
HAVVA KAYA
ACAlperen Ceylan
Alperen Ceylan
KKKadir Kaba
Kadir Kaba
MOMehmet Ozdemir
Mehmet Ozdemir
BFBahadır Feyzioğlu
Bahadır Feyzioğlu
Objectives: The study aimed to investigate the possible effects of coronavirus disease 2019 (COVID-19) on autoantibodies. Patients and methods: Samples of 89,108 individuals (29,033 males, 60,075 females; median: 36 years; range, 0 to 96 years) who underwent autoimmune testing between January 2017 and May 2022 were retrospectively analyzed. The prepandemic period was defined as May 1, 2017, to March 20, 2020, while the pandemic period was defined as March 20, 2020, to May 31, 2022. Results: Of the participants, 0.55% were of foreign nationality. The positivity rate was 18.12%. Autoantibody positivity rates, when analyzed by sex, were higher in females for antinuclear antibody (ANA), antimitochondrial antibody (AMA), anti-liver kidney microsomal (LKM) antibody, immunoglobulin A (IgA) anti-gliadin antibody, anti-endomysial antibody A, anti-ribosomal P protein antibody, anti-Sjögren’s syndrome A (anti-SSA), anti-Sjögren’s syndrome B (anti-SSB), anti-Smith/ribonucleoprotein (anti-SM/RNP), anti-SM, and c-ANCA (cytoplasmic antineutrophil cytoplasmic antibody). When the prepandemic period was compared with the pandemic period, AMA, anti-LKM antibody, IgA anti-gliadin antibody, anti-endomysial antibody A, and anti-SM/RNP levels were higher in the prepandemic period, while ANA was higher during the pandemic. Additionally, statistically significant differences were found in the distributions of ANA, AMA, anti-LKM antibody, IgA anti-gliadin antibody, anti-endomysial antibody A, anti-ribosomal P protein antibody, anti-SM, anti-SSA, and c-ANCA across the years. Conclusion: This study could not establish a cause-effect relationship between the changing autoantibody levels during the COVID-19 pandemic and severe acute respiratory syndrome coronavirus 2 infection due to the lack of results from the same patients across different periods. Nonetheless, we believe the quantitative seroprevalence changes in such a large sample of autoantibody screening results over a five-year period, including the pandemic, are valuable.

29 August 2025 in Abant Medical Journal
Verified
Journal Article
Open access
PDF file
MKMehmet Karabey
Mehmet Karabey
SASema Alacam
Sema Alacam
NKNuran Karabulut
Nuran Karabulut
Background Hepatitis E virus (HEV) infection is one of the most common causes of acute viral hepatitis, and it is estimated to lead to approximately 44,000 deaths annually from 20 million HEV infections worldwide. This study aims to examine the seroprevalence of hepatitis E in our region and to provide an updated contribution to the limited hepatitis E seroprevalence data available in our country. Methods Cases tested for Anti-HEV IgM and Anti-HEV IgG antibodies between January 2021 and October 2023 were analyzed. Hepatitis E-specific IgM and IgG antibodies were analyzed using the EUROIMMUN Anti-HEV IgM and IgG(EUROIMMUN AG, Germany) commercial kits with the Triturus (GRIFOLS,Spain) device. Results The study included 65 patients who were tested for HEV-IgM and HEV-IgG, with a mean age of 29.55±19.56years. Of the 65 patients, 37 were female, 21 were children, and 2 were of foreign nationality. No reactivity was detected in the HEV-IgM tests conducted on the 65 patients. HEV-IgG reactivity was detected in 4 patients, with a seropositivity rate of 6%. All of the HEV seropositive cases were adults, including three males and one female. The HEV seroprevalence was higher in males(10.7%) compared to females(2.7%), with a statistically significant difference between the two groups(p